Bioinspired supramolecular slippery organogels for controlling pathogen spread by respiratory droplets
Surface‐deposited pathogens are sources for the spread of infectious diseases. Protecting
public facilities with a replaceable or recyclable antifouling coating is a promising approach …
public facilities with a replaceable or recyclable antifouling coating is a promising approach …
[HTML][HTML] Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that “slip” through the human mucus barrier
Mucus linings serve as the body's first line of defense at exposed surfaces of the eye and
respiratory, gastrointestinal, and cervicovaginal tracts. The high viscoelasticity and …
respiratory, gastrointestinal, and cervicovaginal tracts. The high viscoelasticity and …
Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier
The intestinal mucus gel layer represents a stumbling block for drug adsorption. This study is
aimed to formulate a nanoparticulate system able to overcome this barrier by cleaving …
aimed to formulate a nanoparticulate system able to overcome this barrier by cleaving …
Nasal adaptive chitosan-based nano-vehicles for anti-allergic drug delivery
M Sun, X Yu, T Wang, S Bi, Y Liu, X Chen - International journal of …, 2019 - Elsevier
Allergic rhinitis (AR) was a chronic airway inflammatory disease. Nasal administration
showed superiorities due to its effective drug absorption. Cetirizine (CTZ) was a common H …
showed superiorities due to its effective drug absorption. Cetirizine (CTZ) was a common H …
Inhalable responsive polysaccharide-based antibiotic delivery nanoparticles to overcome mucus barrier for lung infection treatment
HM Ren, L Han, L Zhang, YQ Zhao, C Lei, Z Xiu… - Nano Today, 2022 - Elsevier
Severe pneumonia caused by bacteria remains a serious clinical challenge, because the
mucus in the lower respiratory tract hinders the effective utilization of antibiotics. Thus, drug …
mucus in the lower respiratory tract hinders the effective utilization of antibiotics. Thus, drug …
Characterization and specification of a trivalent protein-based pneumococcal vaccine formulation using an adjuvant-free nanogel nasal delivery system
Y Yuki, Y Uchida, SI Sawada… - Molecular …, 2021 - ACS Publications
We previously developed a safe and effective nasal vaccine delivery system using a self-
assembled nanosized hydrogel (nanogel) made from a cationic cholesteryl pullulan. Here …
assembled nanosized hydrogel (nanogel) made from a cationic cholesteryl pullulan. Here …
[HTML][HTML] Glycosaminoglycans as multifunctional anti-elastase and anti-inflammatory drugs in cystic fibrosis lung disease
JA Voynow, S Zheng… - Frontiers in pharmacology, 2020 - frontiersin.org
Neutrophil elastase (NE) is a major protease in the airways of patients with cystic fibrosis
(CF) that activates airway inflammation by several mechanisms. NE stimulates epithelial toll …
(CF) that activates airway inflammation by several mechanisms. NE stimulates epithelial toll …
[HTML][HTML] Mucus-penetrating nanosuspensions for enhanced delivery of poorly soluble drugs to mucosal surfaces
Mucus-penetrating Nanosuspensions, consisting of pure hydrophobic therapeutics with
dense muco-inert coatings that enable particles to effectively bypass the mucus barrier …
dense muco-inert coatings that enable particles to effectively bypass the mucus barrier …
[HTML][HTML] Anti-angiogenic nanotherapy inhibits airway remodeling and hyper-responsiveness of dust mite triggered asthma in the Brown Norway rat
GM Lanza, J Jenkins, AH Schmieder, A Moldobaeva… - Theranostics, 2017 - ncbi.nlm.nih.gov
Although angiogenesis is a hallmark feature of asthmatic inflammatory responses,
therapeutic anti-angiogenesis interventions have received little attention. Objective: Assess …
therapeutic anti-angiogenesis interventions have received little attention. Objective: Assess …
Airway epithelial-targeted nanoparticles for asthma therapy
Asthma is a common chronic inflammatory disease associated with intermittent airflow
obstruction caused by airway inflammation, mucus overproduction, and bronchial …
obstruction caused by airway inflammation, mucus overproduction, and bronchial …